EDGAR Filing Documents for 0001558370-20-010689

Form 8-K - Current report:

SEC Accession No. 0001558370-20-010689

Filing Date

2020-08-14

Accepted

2020-08-14 17:18:23

Documents

Period of Report

2020-08-13

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	acrs-20200813x8k.htm iXBRL	8-K	41099
	Complete submission text file	0001558370-20-010689.txt		165085

Data Files

Seq	Description	Document	Type	Size
2	EX-101.SCH	acrs-20200813.xsd	EX-101.SCH	3037
3	EX-101.LAB	acrs-20200813_lab.xml	EX-101.LAB	16724
4	EX-101.PRE	acrs-20200813_pre.xml	EX-101.PRE	10778
5	EXTRACTED XBRL INSTANCE DOCUMENT	acrs-20200813x8k_htm.xml	XML	5028

Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087

Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933

Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)